Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Dendreon: Medicare will cover more Provenge costs
Yahoo/AP
Mon, 11/21/11 - 11:43 am
Tags:
Dendreon, Medicare, Provenge, prostate cancer
Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
Seeking Alpha
Fri, 11/18/11 - 11:37 am
Tags:
Dendreon, Provenge, JNJ, prostate cancer
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
Seeking Alpha
Thu, 11/17/11 - 09:03 am
Tags:
Alnylam, Dendreon, GSK, Medivation, ImmunoCellular, Novartis, cancer, NewLink Genetics
4 Biotech Stocks Predictive Analysts Expect To Underperform
Seeking Alpha
Mon, 11/14/11 - 05:25 pm
Tags:
Dendreon, Seattle Genetics, Sunesis, Alnylam
Five Drugs That Own The Prostate Pipeline
Seeking Alpha
Tue, 11/8/11 - 11:00 am
Tags:
prostate cancer, Dendreon, Provenge, Zytiga, JNJ, Medivation, MVD 3100, Exelixis, cabozantinib, Curtirsen, Teva Pharmaceuticals, OncoGenex
Biotechs And Their Trials By Fire
Seeking Alpha
Mon, 11/7/11 - 11:57 am
Tags:
MannKind, Keryx, Dendreon, Arena, Biocryst, Aeterna Zentaris, Advanced Cell Technologies
Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging
Seeking Alpha
Mon, 11/7/11 - 09:25 am
Tags:
Merck, Dendreon, hepatitis C, Victrelis
Medivation Up 140% In One Day, While Dendreon Gets Quartered
Seeking Alpha
Sat, 11/5/11 - 02:35 pm
Tags:
Medivation, Dendreon, Provenge, MDV3100, prostate cancer
Dendreon beaten down again on so-so Provenge sales update
Fierce Pharma
Thu, 11/3/11 - 11:37 am
Tags:
Dendreon, Provenge, prostate cancern
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Tags:
Dendreon, Provenge, DN24-02, Elan, Tysabri, bapineuzumab, ONYX Pharmaceuticals, Bayer, regorafenib, Carfilzomib, Nexavar, Vertex, Merck, Incivek, Kalydeco, Momenta, Lovenox, Copaxone, Teva Pharmaceuticals
All Eyes On Dendreon With Earnings Set For Wednesday
Seeking Alpha
Sun, 10/30/11 - 12:41 pm
Tags:
Dendreon, earnings
Amgen Is Poised For Continued Success
Seeking Alpha
Wed, 10/26/11 - 09:08 am
Tags:
Amgen, Pharmasset, Dendreon
Dendreon to amp up DTC support for Provenge
Fierce Pharma
Wed, 10/12/11 - 10:43 am
Tags:
DTC, Provenge, prostate cancer, Dendreon
Dendreon's Provenge: Some On The Street Doth Protest Too Much
Seeking Alpha
Mon, 10/10/11 - 12:02 pm
Tags:
Provenge, prostate cancer, Dendreon
Using Options In Speculative Biotech Investing
Seeking Alpha
Mon, 10/10/11 - 11:26 am
Tags:
Antares Pharma, Aeterna Zentaris, options, Dendreon, BioSante, Keryx, Oncothyreon
Real World Costs Impacting Dendreon's Provenge Sales
Seeking Alpha
Sun, 10/9/11 - 03:55 pm
Tags:
Dendreon, Provenge
Dendreon's Earnings Announcement Has Investors Looking For A Sectorwide Turnaround
Seeking Alpha
Thu, 10/6/11 - 01:18 pm
Tags:
earnings, Dendreon
Biotech's Burning Questions for Q3 Earnings
TheStreet.com
Wed, 10/5/11 - 11:01 am
Tags:
earnings, biotech, Dendreon, Vertex, Human Genome Sciences
Dendreon Revisited: What Management Is Saying About Provenge
Seeking Alpha
Tue, 10/4/11 - 10:44 am
Tags:
Dendreon, prostate cancer, Provenge
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Tags:
Achillion, Aeterna Zentaris, Antigenics, Ariad, Amylin, Amarin, BioDelivery Sciences, Cyclacel, Geron, Dendreon, PharmAthene, Zalicus, Human Genome Sciences, Keryx, Peregrine Pharmaceuticals, SIGA technologies, YM BioSciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.